FEops HEARTguideTM vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose FEops HEARTguideTM if…
Choose FEops HEARTguideTM if you require advanced, patient-specific predictive simulations for complex structural heart interventions like TAVI or LAAO. This tool is ideal for optimizing device sizing and positioning by leveraging AI-based anatomical insights from CT scans, ensuring precise pre-procedural planning.
View FEops HEARTguideTM →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your primary goal is the early, non-invasive detection of low ejection fraction during routine physical examinations. This AI-powered solution, integrated with digital stethoscopes, is best suited for quickly identifying patients at risk of heart failure in a general clinical setting.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FEops HEARTguideTM | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Deployment | Cloud-based | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Eko Low Ejection Fraction Tool (ELEFT) integrates with Eko digital stethoscopes to provide rapid results in approximately 15 seconds during routine physical exams, making it highly usable for quick, non-invasive screening. FEops HEARTguideTM, while cloud-based, involves more complex procedure planning with interactive 2D/3D viewers and detailed measurements, requiring more specialized user interaction.
Clinical Value
TieBoth tools offer significant clinical value and are FDA-cleared. FEops HEARTguideTM provides predictive simulations to optimize device sizing and positioning for complex structural heart interventions, directly impacting procedure success and safety. ELEFT aids in the early detection of low ejection fraction, a key indicator of heart failure, during routine exams, which can lead to earlier intervention and improved long-term outcomes for a widespread condition.
Pricing & Value
TieNeither company publicly discloses pricing information, requiring direct contact for quotes. FEops HEARTguideTM operates on a service-based model per analysis, while ELEFT is part of Eko's SENSORAu2122 enterprise platform. Without specific pricing details, it is impossible to definitively determine which offers better value.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being cloud-based, HIPAA compliant, offering BAAs, and FDA cleared. FEops HEARTguideTM features a DICOM interface for seamless integration into clinical imaging workflows, while ELEFT is explicitly part of an 'enterprise solution' (SENSORAu2122 platform) and integrates with physical Eko digital stethoscopes, indicating robust deployment capabilities within healthcare systems.
Innovation
FEops HEARTguideTMFEops HEARTguideTM leverages advanced 'digital twin' technology and predictive simulation for device-anatomy interaction, offering a highly personalized and complex approach to pre-procedural planning that pushes the boundaries of AI in simulating patient-specific physiology. ELEFT is innovative in bringing AI-powered diagnostics for early heart failure detection to routine physical exams with rapid results, but FEops' core technology represents a more fundamental scientific and engineering advancement.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Eko Health, the company behind ELEFT, provides a dedicated 'Support' section on its website, offering FAQs, user manuals for its digital stethoscopes, and clear contact information, indicating a structured and publicly accessible support ecosystem. FEops' public information on explicit support documentation is less readily available, though their website mentions 'customer success' and 'training'.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FEops HEARTguideTM | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Name | FEops HEARTguideTM | Eko Low Ejection Fraction Tool (ELEFT) |
| Primary Function | Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. | FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Company | FEops nv | Eko Health |
| Core Functionality | Predictive simulation technology for device-anatomy interaction, AI-based anatomical measurements from CT scans, segmentation of cardiovascular structures. | AI-powered low ejection fraction detection, analyzes ECG and heart sound recordings, aids in early identification of heart failure risk. |
| Integration/Workflow | DICOM interface for easy integration into clinical workflow, cloud-based platform with access from anywhere at any time. | Integrates with FDA-cleared Eko digital stethoscopes, provides results in approximately 15 seconds. |
| Target Specialties | Cardiology, Cardiothoracic Surgery, Radiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring FEops HEARTguideTM and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring FEops HEARTguideTM or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.